NBIXHealthcareLarge-Cap

NEUROCRINE BIOSCIENCES INC Insider Trading Activity

Every SEC Form 4 insider transaction reported for NEUROCRINE BIOSCIENCES INC (NBIX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are NBIX insiders buying or selling?

NEUROCRINE BIOSCIENCES INC insiders reported 0 open-market buys ($0) and 365 sells ($520.4M) across 365 Form 4 filings — a net selling position of $520.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 13, 2026)

Total Form 4 filings
365
SEC EDGAR
Insider filers
21
Insider buys (0)
$0
Insider sells (365)
$520.4M

Insider sentiment

Net selling

Net insider flow of $520.4M in net selling.

Recent NBIX insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 13, 2026Ingrid DelaetChief Regulatory OfficerSale4.4K$181.02$790.5K
Jul 13, 2026Darin LippoldtChief Legal OfficerSale10.0K$179.60$1.8M
Jul 9, 2026Ingrid DelaetChief Regulatory OfficerSale14.6K$178.65$2.6M
Jun 30, 2026Darin LippoldtChief Legal OfficerSale10.0K$170.15$1.7M
Jun 9, 2026SHERWIN STEPHEN ADirectorSale25.0K$165.32$4.1M
Jun 8, 2026Leslie V NorwalkDirectorSale1.3K$168.06$210.1K
Jun 4, 2026Julie CookeChief Human Resources OfficerSale36.9K$156.22$5.8M
Jun 2, 2026Jude OnyiaChief Scientific OfficerSale11.0K$160.25$1.8M
Jun 2, 2026Ingrid DelaetChief Regulatory OfficerSale2.3K$156.71$354.3K
May 29, 2026Jude OnyiaChief Scientific OfficerSale11.0K$155.53$1.7M
May 28, 2026David W. BoyerChief Corp. Affairs OfficerSale3.9K$156.64$609.0K
May 21, 2026Kevin Charles GormanDirectorSale245.1K$154.33$37.8M
May 18, 2026POPS RICHARD FDirectorSale15.0K$157.65$2.4M
May 14, 2026Leslie V NorwalkDirectorSale3.8K$155.01$590.6K
Jan 20, 2026Kyle GanoChief Executive OfficerSale36.4K$132.70$4.8M
Dec 17, 2025Leslie V NorwalkDirectorSale6.2K$152.78$945.7K
Dec 10, 2025Darin LippoldtChief Legal OfficerSale4.4K$159.65$698.6K
Dec 4, 2025LYONS GARY ADirectorSale15.0K$152.61$2.3M
Dec 2, 2025Eric BenevichChief Commercial OfficerSale6.0K$151.74$905.9K
Nov 26, 2025MORROW GEORGE JDirectorSale15.0K$143.37$2.2M
Nov 6, 2025William H RastetterDirectorSale18.0K$151.82$2.7M
Nov 5, 2025Kyle GanoChief Executive OfficerSale300$141.97$42.6K
Aug 11, 2025Kevin Charles GormanDirectorSale106.3K$126.41$13.4M
Jul 11, 2025Ingrid DelaetChief Regulatory OfficerSale457$135.00$61.7K
Jul 11, 2025Jude OnyiaChief Scientific OfficerSale59.8K$130.46$7.8M

Showing the 25 most recent of 365 Form 4 filings for NEUROCRINE BIOSCIENCES INC.

Most active NBIX insiders

  • Darin Lippoldt39 filings
  • Eric Benevich33 filings
  • Julie Cooke31 filings
  • Kevin Charles Gorman26 filings
  • Eiry Roberts25 filings

Ask anything about NBIX insider activity

Use Trabud's AI agent to query NEUROCRINE BIOSCIENCES INC's Form 4 history in plain English — "Show me NBIX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

NBIX insider trading FAQ

Are NEUROCRINE BIOSCIENCES INC insiders buying or selling?

Across 365 SEC Form 4 filings, NEUROCRINE BIOSCIENCES INC (NBIX) insiders reported 0 open-market purchases totaling $0 and 365 sales totaling $520.4M. That is a net selling position of $520.4M.

How many insiders trade NBIX stock?

21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for NEUROCRINE BIOSCIENCES INC. The most recent filing was accepted on Jul 13, 2026.

Where does Trabud get NBIX insider trading data?

All NBIX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content